Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
TB-500 (thymosin beta-4 active fragment) is used off-label for cardioprotection. Review the preclinical evidence, monitoring requirements, dosing considerations, and safety profile.
Read clinical reviewTB-500 (thymosin beta-4 active fragment) is used off-label for muscle recovery. Review the preclinical evidence, reported dosing protocols, safety signals, and FDA status before considering this peptide.
Read clinical reviewA clinical review of TB-500 (thymosin beta-4 active fragment) for muscle recovery, including preclinical evidence, off-label status, dosing protocols, and safety considerations.
Read clinical reviewTB-500 (thymosin beta-4 active fragment) is used off-label for muscle recovery. Review the preclinical evidence, monitoring requirements, dosing protocols, and safety considerations.
Read clinical reviewA clinical evidence review of TB-500 (thymosin beta-4 active fragment) for wound healing, including preclinical data, off-label use context, dosing protocols, and safety considerations.
Read clinical reviewTB-500 (thymosin beta-4 active fragment) is used off-label for wound healing. Review the preclinical evidence, proposed dosing protocols, safety considerations, and FDA status.
Read clinical reviewTB-500 (thymosin beta-4 active fragment) is used off-label for wound healing. Review the preclinical evidence, safety concerns, regulatory status, and what clinicians actually know about this peptide.
Read clinical review